Blog

Preparing for COVID-19, Impacts on Research Organizations

The rapidly evolving federal, state, and local policies regarding COVID-19 are impacting every walk of life in the United States and around the world. Companies,...

Read The Article

COVID-19 Vaccine Phase 1 Trial Begins

NIH is conducting a Phase 1 clinical trial of a new vaccine for COVID-19. Phase 1 research is the first clinical trial phase conducted with...

Read The Article

Time to revisit your disaster plan?

Introduction COVID-19 dominates daily news headlines as communities and organizations evaluate policies regarding public gatherings, quarantines, and other issues. Many states, including New York and...

Read The Article

Research During Global Health Emergencies

Complying with research ethics is notably challenging during global health emergencies such as the outbreak of coronavirus disease (COVID-19). Investigators must have an ethical framework...

Read The Article

U.S. Federal Regulatory Agencies Provide Guidance for Clinical Trials in Response to COVID-19

As COVID-19 continues to impact research organizations and clinical sites, federal agencies are issuing guidance for clinical trials. Organizations are closing or dramatically reducing operations...

Read The Article

Compliance With Posting Clinical Trials Results on ClinicalTrials.gov

Both the journals Science and The Lancet have recently published studies showing a lack of compliance with posting clinical trials results on ClinicalTrials.gov. Be sure...

Read The Article

Ethical Considerations for Replicating Bones with 3D Printing

Evolving technology now makes 3D printing an inexpensive technology for reproducing replica bones. Digital bone repositories around the world are currently working through the ethical...

Read The Article

Webcast of NAS Workshop, An Examination of Emerging Bioethical Issues in Biomedical Research

The National Academy of Sciences, Engineering, and Medicine will be hosting An Examination of Emerging Bioethical Issues in Biomedical Research on February 26, 2020 at...

Read The Article

The Importance of Improving ClinicalTrials.gov Compliance

For two decades, the federal government has encouraged transparency in research. As a result of these efforts, it established ClinicalTrials.gov, a national registry of U.S....

Read The Article

Improving Drugs Through Patient-Centric Design for Clinical Trials

Read about the approach to drug development that includes tolerability, ease of use, compliance with therapy, and quality of life as topics addressed along with...

Read The Article